CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT01905475

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Polyphor Ltd. (from the registry)
Registry
  • NCT NCT01905475
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, Germany, Hungary, Poland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01905475. Randomized; quadruple masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2015-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)
Acronym
CATCH-AMI
Condition
Large Reperfused ST-Elevation Myocardial Infarction
Intervention (Drug)
POL6326
Intervention (Drug)
Placebo
Lead sponsor
Polyphor Ltd. (class: industry)

Record details

Record id
cardio:ct-nct01905475
Content hash
9a41d1b67be2adf7ee2360b666b020fcced54c459a7aec4f5f6278ca80fe9543